https://www.selleckchem.com/pr....oducts/pyridostatin-
R2* estimation reflects the paramagnetism of the tumor tissue, which may be used to differentiate between benign and malignant liver lesions when contrast agents are contraindicated. To investigate whether R2* derived from multi-echo Dixon imaging can aid differentiating benign from malignant focal liver lesions (FLLs) and the impact of 2D region of interest (2D-ROI) and volume of interest (VOI) on the outcomes. We retrospectively enrolled 73 patients with 108 benign or malignant FLLs. All patients underwent c
Like
Comment
Share
